TABLE 4.
Genes | Before challenge |
0.85% NaCl history |
2 M glucose history |
P-value1 |
||||||
0.85% NaCl history | 2 M glucose history | P-value | CHO-M | CHO-H | CHO-M | CHO-H | History | Diet | Interaction | |
Liver glycolysis at week 20 | Liver glycolysis at week 24 | |||||||||
gck | 0.4 ± 0.3 | 0.8 ± 0.2 | 0.027 | 0.5 ± 0.2 | 1.0 ± 0.3 | 1.3 ± 1.0 | 2.4 ± 0.8 | 0.001 | 0.010 | 0.329 |
pfklr | 1.0 ± 1.0 | 0.9 ± 0.4 | 0.810 | 1.4 ± 0.9 | 1.8 ± 1.4 | 2.6 ± 2.2 | 2.0 ± 1.9 | 0.314 | 0.889 | 0.485 |
pklr | 1.4 ± 1.4 | 0.8 ± 0.3 | 0.325 | 1.0 ± 0.2 | 1.1 ± 0.7 | 1.3 ± 0.5 | 1.6 ± 0.3 | 0.024 | 0.360 | 0.655 |
Liver gluconeogenesis at week 20 | Liver gluconeogenesis at week 24 | |||||||||
g6pca1 | 1.3 ± 0.5 | 1.4 ± 0.8 | 0.626 | 1.3 ± 0.5 | 0.9 ± 0.4 | 1.1 ± 0.4 | 0.8 ± 0.1 | 0.313 | 0.059 | 0.715 |
g6pca2 | 0.9 ± 0.3 | 1.2 ± 0.4 | 0.103 | 1.6 ± 0.9 | 0.9 ± 0.4 | 1.4 ± 0.5 | 0.8 ± 0.5 | 0.856 | 0.003 | 0.477 |
pck1 | 0.6 ± 0.4 | 1.4 ± 1.3 | 0.230 | 1.5 ± 0.9 | 0.8 ± 0.5 | 0.8 ± 0.6 | 0.2 ± 0.1 | 0.016 | 0.010 | 0.779 |
pck2 | 0.7 ± 0.3 | 0.7 ± 0.6 | 0.938 | 2.9 ± 1.8 | 0.6 ± 0.6 | 1.7 ± 1.4 | 0.7 ± 0.4 | 0.244 | 0.003 | 0.209 |
Liver lipogenesis at week 20 | Liver lipogenesis at week 24 | |||||||||
fasn | 1.2 ± 1.0 | 1.0 ± 0.3 | 0.682 | 1.1 ± 0.8 | 1.3 ± 0.8 | 1.1 ± 0.8 | 2.3 ± 0.2 | 0.087 | 0.031 | 0.111 |
g6pd | 0.9 ± 0.5 | 1.3 ± 0.7 | 0.328 | 0.9 ± 0.4 | 1.4 ± 0.7 | 0.9 ± 0.3 | 2.4 ± 1.2 | 0.077 | 0.007 | 0.211 |
Liver amino acid catabolism at week 20 | Liver amino acid catabolism at week 24 | |||||||||
asat | 0.9 ± 0.5 | 1.3 ± 0.5 | 0.266 | 1.4 ± 0.5b | 0.4 ± 0.2c | 2.1 ± 0.5a | 0.2 ± 0.1c | 0.119 | < 0.001 | 0.010 |
alat | 0.9 ± 0.4 | 1.1 ± 0.2 | 0.280 | 2.3 ± 1.6 | 1.1 ± 0.7 | 2.7 ± 1.3 | 1.0 ± 0.4 | 0.810 | 0.005 | 0.651 |
gdh | 1.0 ± 0.5 | 1.2 ± 0.2 | 0.470 | 1.7 ± 0.5 | 1.2 ± 0.4 | 1.7 ± 0.7 | 1.3 ± 0.3 | 0.937 | 0.039 | 0.904 |
Glucose transport and muscle metabolism at week 20 | Glucose transport and muscle metabolism at week 24 | |||||||||
glut4 | 0.8 ± 0.4 | 1.2 ± 0.3 | 0.071 | 0.6 ± 0.4 | 0.8 ± 0.1 | 1.1 ± 0.3 | 1.1 ± 0.4 | 0.005 | 0.327 | 0.631 |
hk1 | 0.8 ± 0.3 | 1.2 ± 0.3 | 0.047 | 0.7 ± 0.2 | 0.9 ± 0.2 | 0.9 ± 0.2 | 1.2 ± 0.2 | 0.019 | 0.018 | 0.656 |
hk2 | 0.7 ± 0.3 | 1.1 ± 0.3 | 0.030 | 0.8 ± 0.2 | 0.9 ± 0.4 | 1.1 ± 0.3 | 1.2 ± 0.1 | 0.009 | 0.225 | 0.752 |
pfkma | 0.8 ± 0.4 | 1.2 ± 0.7 | 0.262 | 1.0 ± 1.0 | 0.7 ± 0.2 | 0.7 ± 0.3 | 0.9 ± 0.5 | 0.853 | 0.825 | 0.305 |
pfkmb | 1.1 ± 0.2 | 0.8 ± 0.3 | 0.165 | 1.2 ± 0.6 | 0.9 ± 0.3 | 1.0 ± 0.3 | 1.1 ± 0.2 | 0.971 | 0.407 | 0.237 |
pkma | 0.8 ± 0.3 | 1.0 ± 0.4 | 0.617 | 0.8 ± 0.1b | 0.8 ± 0.2b | 0.7 ± 0.1b | 1.1 ± 0.2a | 0.205 | 0.002 | 0.015 |
1Two-way ANOVA was used to analyze the effects of glucose injection (History), challenging diet (Diet) and their interaction (History × Diet). Different letters indicate significant differences in the mean values for four combination groups (P < 0.05).